{"_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk2q-ACQw","type":"Investor","logokey":"$l1Eh9WWNy3EChfjMvpqa61jGaw60ynLnTZDjS5SeC8WzleM7ZMkGRM","name":"ARCH Venture Partners","subtype":"VC and Private Equity","lastupdate":"2022-06-14T00:00:00.000Z","update_date":"2022-06-14T00:00:00.000Z","lastModified":"Oct 6, 2024","active":1,"confidence_score":25,"confidence_score_reason":"product stage, sector, number of employees, tags, invite member, business model, tag line, description, homepage, video or image, funding rounds, markets, external profiles, not claimed","urlname":"arch-venture-partners","minimal_profile":1,"hide_reason":null,"status":"Active","fullstatus":"Active","hide_reason_data":null,"acquired":null,"description_edited":null,"tag_line_edited":null,"isisraeli":0,"country":"United States","formernames":[],"min_date_investments":"2006-11-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":null,"founded_year":1986,"iia_supported":null,"currently_iia_supported":null,"alternativenames":null,"managedassets":"Undisclosed","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"","website":"","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"investmentstage":["Pre-Seed","Seed","A Round"],"about":"A venture firm specializing in early-stage investments aimed at life science innovations to prevent, detect, and cure diseases.","founded":"1/1986","education":null,"additional_activities":null,"techcommunityinvolvement":null,"exits":[{"date":"Jul 2015","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODwq4OjCww","mnatype":null,"eventtype":"POEvent","valuation":"$562M","wasacquired":null,"capitalraised":"$102M","stockexchange":"NASDAQ","eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"Chiasma","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6sq9wKDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/chiasma","acquiredcompany_mna_logokey":"$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","acquiredcompany_mna_urlname":"chiasma","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""}],"funds":[{"date":"Sep 2024","name":"13","title":"Fund 13","amount":"$3B","source":"https://www.biopharmadive.com/news/arch-venture-biotech-startup-fund-artificial-intelligence/728100/","eventid":"BX4koIGQ3f15AOEPx6fOLOrhHngxX3CyfxsHa9j1oQcb67qE11xfAc","visibilitytype":"Public","amountvisibility":"Public","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":""}],"portfolio":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6sq9wKDA","name":"Chiasma","hidden":false,"raised":"$293.7M","founded":"2001","fullurl":"/company_page/chiasma","logokey":"$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","urlname":"chiasma","employees":"11-50","description":"Oral Therapeutic Options for Patients with Rare Diseases","fundingstage":"Acquired","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":293700000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Feb 2015","name":"Chiasma","amount":70000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD428vxCAw","fullurl":"/company_page/chiasma","logokey":"$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","tagline":"Oral Therapeutic Options for Patients with Rare Diseases","urlname":"/company_page/chiasma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6sq9wKDA","isfollowon":1,"companytype":"Startup","eventamount":"$70M","fundingtype":"E Round","investmentid":"eaabc32b-b118-433c-8ae2-0eaa0805d7fd","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2014","name":"Chiasma","amount":33500000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEvOWRCww","fullurl":"/company_page/chiasma","logokey":"$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","tagline":"Oral Therapeutic Options for Patients with Rare Diseases","urlname":"/company_page/chiasma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6sq9wKDA","isfollowon":1,"companytype":"Startup","eventamount":"$33.5M","fundingtype":"D Round","investmentid":"4fa3e4fd-2fe9-4d41-9e0c-2cd77df08011","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Nov 2006","name":"Chiasma","amount":44000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD427q_CAw","fullurl":"/company_page/chiasma","logokey":"$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","tagline":"Oral Therapeutic Options for Patients with Rare Diseases","urlname":"/company_page/chiasma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6sq9wKDA","isfollowon":0,"companytype":"Startup","eventamount":"$44M","fundingtype":"C Round","investmentid":"fbdf4c6e-a115-466e-a6b6-8483a69df16f","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$z6o9L8zBR5bYzHtPOvKBaNrmcAjYf4Prn6m3JG7dIlwdzzTgaNj9db","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""}],"team":[],"tags":["life-sciences","biotechnology"],"targetmarkets":[],"phone":null,"address":{"israeli":[],"officesabroad":[{"id":"tvBPSzQEcVWDFESCKsgXxU437HA1Bjec1bBcJdm1BGKRHCWH8y26nn","city":"Chicago","address":"Chicago, IL, USA","country":"United States","placeid":"ChIJ7cv00DwsDogRAMDACa2m4K8"}]},"headquarter_address":null,"news":[{"id":"jtjBJVCHogZO5Sx3BW0LcfwgLTVk0ur9BsjM7tK9EAsUfrnKDUfzwG","date":"Sep 26, 2024","link":"https://www.biopharmadive.com/news/arch-venture-biotech-startup-fund-artificial-intelligence/728100/","source":"www.biopharmadive.com","visible":1,"analysis":{"tags":"biotech investment","company":"Arch Venture Partners","layoffs":null,"summary":"Arch Venture Partners has successfully raised over $3 billion for its 13th fund, continuing its strategy of investing in cutting-edge biotechnology startups. The firm, known for its focus on high-powered computing tools and artificial intelligence in drug discovery, remains a key player in the biotech sector despite challenging market conditions. Archs recent investments include a $1 billion funding round for Xaira Therapeutics, an AI-driven biotech startup. The firm emphasizes early-stage investments and ensuring strong leadership in its portfolio companies. Other notable biotech venture firms raising funds this year include Foresite Capital, Flagship Pioneering, Sands Capital, and Scion Life Sciences.","partners":[],"customers":[],"investors":[],"confidence":10,"key_topics":["biotech","investment","AI","drug discovery","healthcare"],"date_of_event":"2024","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$3 billion","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ydbFtaZwhcEab7OCMHWxFGsJAtgIDbynRrUN836aPhQh6mcOvYSMKU","news_summary":"Arch raises another $3B biotech fund in pursuit of ‘coolest’ new science","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"00E5X7sUiBYGZ9As0ujyBUbxX3tMAmx3gg8hGeU6BKcnk5zkG0T2YY","date":"Feb 2, 2024","link":"https://www.statnews.com/2024/02/02/arch-venture-partners-is-raising-3-billion-for-a-life-sciences-fund/","source":"www.statnews.com","visible":1,"analysis":{"tags":"Investment, Fundraising","company":"ARCH Venture Partners","layoffs":"Not mentioned","summary":"ARCH Venture Partners, a leading investor in the biotech ecosystem, is planning to raise $3 billion for its 13th fund. The Chicago-based firm has filed the necessary paperwork with the Securities and Exchange Commission. The amount they aim to raise is similar to what they raised in their most recent fundraising in 2022.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":["Biotech","Fundraising"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"Growth-Positive","investment_amount":"$3 billion","structured_issues":["Investment"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"23Q10UtGCTH2uQb9HdvoXV1VsrbN7YFR37cFYLqExiw1DFGpDsoZOd","news_summary":"ARCH Venture Partners is raising $3 billion for a life sciences fund","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":2,"mediagallery":[],"biverification":null,"sectorverify":null,"biverify":null,"biverifydate":null,"crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"RPA","creator_email":"sncentraltest@gmail.com","createdate":"2019-05-11T00:00:00.000Z","recentupdates":[{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-10-06 11:14:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-10-06 11:14:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-04 07:18:42.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-10-06 11:14:12.000000","last_name":"Wein","first_name":"Ortal"}],"rounds_per_sector":[{"count":3,"sector":"Health Tech & Life Sciences"}],"rounds_per_stage":[{"count":1,"isfollowon":0,"fundingStage":"C Round"},{"count":1,"isfollowon":1,"fundingStage":"D Round"},{"count":1,"isfollowon":1,"fundingStage":"E Round"}],"investment_rounds_over_time":[{"year":2006,"month":11,"record_count":1},{"year":2014,"month":12,"record_count":1},{"year":2015,"month":2,"record_count":1}],"portfolio_companies_per_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"new_portfolio_companies_over_time":[{"year":2006,"month":11,"record_count":1}],"exits_over_time":[{"year":2015,"count":3,"eventType":"POEvent"}],"exits_by_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"affiliatedOrganizations":null,"timeline":[{"id":"BX4koIGQ3f15AOEPx6fOLOrhHngxX3CyfxsHa9j1oQcb67qE11xfAc","date":"2024-09-01","name":"13","title":"Fund 13","amount":3000000000,"source":"https://www.biopharmadive.com/news/arch-venture-biotech-startup-fund-artificial-intelligence/728100/","eventtype":"InvestmentFirmFundingEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"style":"","hiddenCompanyTooltip":""}],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"VC and Private Equity","parsedName":"ARCH Venture Partners","logourl":"https://storage.googleapis.com/clean-finder-353810/$l1Eh9WWNy3EChfjMvpqa61jGaw60ynLnTZDjS5SeC8WzleM7ZMkGRM","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$l1Eh9WWNy3EChfjMvpqa61jGaw60ynLnTZDjS5SeC8WzleM7ZMkGRM","teamMembersNumber":0,"section":null,"sectionParams":"","queryParams":"","seoabout":"A venture firm specializing in early-stage investments aimed at life science innovations to prevent, detect, and cure diseases.","seoTitle":"Foreign VC and Private Equity","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"C Round\",\"newInvestments\":1,\"followOnInvestments\":0},{\"fundingStage\":\"D Round\",\"newInvestments\":0,\"followOnInvestments\":1},{\"fundingStage\":\"E Round\",\"newInvestments\":0,\"followOnInvestments\":1}],\"investmentRoundsBySector\":[{\"count\":3,\"sector\":\"Health Tech & Life Sciences\"}],\"investmentRoundsOverTime\":[{\"label\":\"2006\",\"count\":1},{\"label\":\"2007\",\"count\":0},{\"label\":\"2008\",\"count\":0},{\"label\":\"2009\",\"count\":0},{\"label\":\"2010\",\"count\":0},{\"label\":\"2011\",\"count\":0},{\"label\":\"2012\",\"count\":0},{\"label\":\"2013\",\"count\":0},{\"label\":\"2014\",\"count\":1},{\"label\":\"2015\",\"count\":1},{\"label\":\"2016\",\"count\":0},{\"label\":\"2017\",\"count\":0},{\"label\":\"2018\",\"count\":0},{\"label\":\"2019\",\"count\":0},{\"label\":\"2020\",\"count\":0},{\"label\":\"2021\",\"count\":0},{\"label\":\"2022\",\"count\":0},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2006\",\"count\":1},{\"label\":\"2007\",\"count\":0},{\"label\":\"2008\",\"count\":0},{\"label\":\"2009\",\"count\":0},{\"label\":\"2010\",\"count\":0},{\"label\":\"2011\",\"count\":0},{\"label\":\"2012\",\"count\":0},{\"label\":\"2013\",\"count\":0},{\"label\":\"2014\",\"count\":0},{\"label\":\"2015\",\"count\":0},{\"label\":\"2016\",\"count\":0},{\"label\":\"2017\",\"count\":0},{\"label\":\"2018\",\"count\":0},{\"label\":\"2019\",\"count\":0},{\"label\":\"2020\",\"count\":0},{\"label\":\"2021\",\"count\":0},{\"label\":\"2022\",\"count\":0},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[{\"year\":2015,\"count\":3,\"eventType\":\"POEvent\"},{\"year\":2006,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2006,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2007,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2007,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2008,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2008,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2009,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2009,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2010,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2010,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2011,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2011,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2012,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2012,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2013,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2013,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2014,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2014,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2016,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2016,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2017,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2017,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2018,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2018,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2019,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2019,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2020,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2020,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2021,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2021,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2022,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2023,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2023,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2024,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2024,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2025,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2025,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2026,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2026,\"count\":0,\"eventType\":\"publicExits\"}],\"exitsBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}]}","statusinfo":"","iiasupport":"","managedAssetsNumber":null,"investmentrange":"$33.5M - $70M","communityinvolvement":[],"foreignInvestments":"","nationality":"Foreign","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{}}